MPO TIP FR-TI1/625
« backIntellMed, Ltd. participates in the project of the Ministry of Industry and Trade called New derivatives of 5-azacytosine nucleosides like demethylating therapeutics: identification of clinical candidates and efficiency biomarkers (MPO TIP FR-TI1/625).The project is focused to the development of new hypomethylating agents based on polymer conjugates of 5-azacytosine nucleosides and their 5,6-dihydro congeners, which will increase plasma half-life of the drug. This will not only pronounce therapeutical effect and increase survival time of patients, but also allow application by standard qick infusion in a single dose instead of continuous several-day infusion. Cost for the therapy will be significantly reduced in this way also by removing the necessity of hospitalisation